Skip to main content
SpringerLink
Log in

Pitfalls in the Design, Analysis, Presentation, and Interpretation of Randomized Clinical Trials

  • Chapter
  • First Online:
Advances in Radiation Oncology in Lung Cancer

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 1729 Accesses

Abstract

Randomised clinical trials are the gold standard tool for testing new treatments, but need to confirm to certain basic guidelines in order to be considered reliable. Good trial design, analysis, presentation and interpretation and an awareness of the common pitfalls are likely to maximise the relevance and impact of the trial.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Clarke M, Chalmers I (1998) Discussion sections in reports of controlled trials published in general medical journals: Islands in search of continents? JAMA 280:280–282

    Article  PubMed  CAS  Google Scholar 

  • Clarke M, Alderson P, Chalmers I (2002) Discussion sections in reports of controlled trial published in general medical journals. JAMA 287:2799–2801

    Article  PubMed  Google Scholar 

  • Fossella FV, DeVore R, Kerr RN, Crawford J, Natale RR et al (2000) Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small cell lung cancer previously treated with platinum-containing chemotherapy regimens. J Clin Oncol 18:2354–2362

    PubMed  CAS  Google Scholar 

  • Fukuoka M, Yano S, Giaccone G, Tamura T, Nagagawa K et al (2003) Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small cell lung cancer. J Clin Oncol 21:2237–2246

    Article  PubMed  CAS  Google Scholar 

  • Gatzemeier U, von Pawel J, Gottfried M, ten Velde GPM, Mattson K et al (2000) Phase III comparative study of high dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small cell lung cancer. J Clin Oncol 18:3390–3399

    PubMed  CAS  Google Scholar 

  • Georgoulias V, Papadakis E, Alexopoulos A, Tsiafaki X, Rapti A et al (2001) Platinum-based and non-platinum-based chemotherapy in advanced non-small cell lung cancer: a randomised multicentre trial. Lancet 357:1478–1484

    Article  PubMed  CAS  Google Scholar 

  • Gore EM, Bae K, Wong SJ, Sun A, Bonner JA et al (2011) Phase III Comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. J Clin Oncol 29:272–278

    Article  PubMed  Google Scholar 

  • Kelly K, Crowley J, Bunn PA Jr, Presant CA, Grevstad PK et al (2001) Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a southwest oncology group trial. J Clin Oncol 19:3210–3218

    PubMed  CAS  Google Scholar 

  • Langendijk H, de Jong J, Tjwa M, Muller M, ten Velde G et al (2001) External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. Rad Oncol 58:257–268

    Article  CAS  Google Scholar 

  • Lee JJ (2011) Demystify statistical significance—time to move on from the p value to Bayesian analysis. J Natl Cancer 103:2–3

    Article  Google Scholar 

  • Non-Small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311:899–909

    Article  Google Scholar 

  • Pujol J-L, Daures J-P, Riviere A, Quoix E, Westell V et al (2001) Etoposide plus cisplatin with or without the combination of 4′-epidoxorubicin plus cyclophosphamide in treatment of extensive small cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study. J Natl Cancer Inst 93:300–308

    Article  PubMed  CAS  Google Scholar 

  • Ranson M, Davidson N, Nicolson M, Falk S, Carmichael J et al (2000) Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small cell lung cancer. J Natl Cancer Inst 92:1074–1080

    Article  PubMed  CAS  Google Scholar 

  • Rosell R, Gomez-Condina J, Camps C, Maestre J, Padilla J et al (1994) A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 330:153–158

    Article  PubMed  CAS  Google Scholar 

  • Roszkowski K, Pluzanska A, Krzakowski M, Smith AP, Saigi E et al (2000) A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naïve patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC). Lung Cancer 27:145–147

    Article  PubMed  CAS  Google Scholar 

  • Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB et al (1994) A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIa non-small cell lung cancer. J Natl Cancer Inst 86:673

    Article  PubMed  CAS  Google Scholar 

  • Sandler AB, Nemunaitis J, Denham C, von Pawel J, Cormier Y et al (2000) Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small cell lung cancer. J Clin Oncol 18:122–130

    PubMed  CAS  Google Scholar 

  • Sause W, Kolesar P, Taylor IV S, Johnson D, Livingston R et al (2000) Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer. Chest 117:358–364

    Article  PubMed  CAS  Google Scholar 

  • Scagliotti GV, Fossati R, Torri V, Crino L, Giaconne G et al (2003) Randomized study of adjuvant chemotherapy for completely resected stage I, II or IIIa non-small cell lung cancer. J Natl Cancer Inst 95:1453–1461

    Article  PubMed  CAS  Google Scholar 

  • Schiller JH, Harrington D, Belani CP, Langer C, Sandler A et al (2002) Comparison of four chemotherapy regimens for advanced non-small cell lung cancer. N Engl J Med 346:92–98

    Article  PubMed  CAS  Google Scholar 

  • Sculier JP, Paesmans M, Lecomte J, van Cutsem O, Lafitte JJ et al (2001) A three-arm phase III randomised trial assessing, in patients with extensive disease small cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics. Br J Cancer 85:1444–1451

    Article  PubMed  CAS  Google Scholar 

  • Shepherd FA, Giaccone G, Seymour L, Debruyne C, Bezjak A et al (2002) Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small cell lung cancer: a trial of the national Cancer Institute of Canada-Clinical Trials group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 20:4434–4439

    Article  PubMed  CAS  Google Scholar 

  • Socinski MA, Schell MJ, Peterman A, Bakri K, Yates S et al (2002) Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced stage IIIb/IV non-small cell lung cancer. J Clin Oncol 20:1335–1343

    Article  PubMed  CAS  Google Scholar 

  • Splinter TA, Sahmoud T, Festen J, van Zandwijk N, Sorenson S et al (1996) Two schedules of teniposide with or without cisplatin in advanced non-small cell lung cancer: a randomized study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 14:127–134

    PubMed  CAS  Google Scholar 

  • Sundstrom S, Bremnes RM, Kaasa S, Aasebo U, Hatlevoll R et al (2002) Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin and vincristine regimen in small cell lung cancer: results from a randomized phase III trial with 5 years’ follow-up. J Clin Oncol 20:4665–4672

    Article  PubMed  CAS  Google Scholar 

  • Tada H, Tsuchiya R, Ichinose Y, Koike T, Nishizawa N, Nagai K, Kato H (2004) A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304). Lung Cancer 43:167–173

    Article  PubMed  Google Scholar 

  • Takada M, Fukuoka M, Kawahara M, Sugiura T, Yokohama A et al (2002) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited stage small cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 20:3054–3060

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Trials Unit, London, UK

    Richard Stephens

Authors
  1. Richard Stephens
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard Stephens .

Editor information

Editors and Affiliations

  1. Institute of Lung Diseases, Institutski put 4, Sremska Kamenica, 21204, Serbia

    Branislav Jeremic

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stephens, R. (2011). Pitfalls in the Design, Analysis, Presentation, and Interpretation of Randomized Clinical Trials. In: Jeremic, B. (eds) Advances in Radiation Oncology in Lung Cancer. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2011_282

Download citation

  • DOI: https://doi.org/10.1007/174_2011_282

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-19924-0

  • Online ISBN: 978-3-642-19925-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation